Illumina Researcher Outlines Strategy for Interpreting Clinical Information in Healthy Genomes | GenomeWeb

By Andrea Anderson

VANCOUVER, BRITISH COLUMBIA (GenomeWeb News) – At the American College of Medical Genetics annual meeting here this week, Illumina UK researcher Mark Ross discussed strategies that Illumina researchers are using to interpret information in genome sequences from healthy individuals generated through the company's clinical whole-genome sequencing service.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.